Your browser doesn't support javascript.
loading
Intratumoral, rather than stromal, CD8+ T cells could be a potential negative prognostic marker in invasive breast cancer patients.
Catacchio, Ivana; Silvestris, Nicola; Scarpi, Emanuela; Schirosi, Laura; Scattone, Anna; Mangia, Anita.
Afiliação
  • Catacchio I; Functional Biomorphology Laboratory, IRCCS Istituto Tumori "Giovanni Paolo II" di Bari, Italia. Electronic address: ivana.84@libero.it.
  • Silvestris N; Medical Oncology Unit and Scientific Directorate IRCCS Istituto Tumori "Giovanni Paolo II" di Bari, Italia. Electronic address: silvestrisnicola@libero.it.
  • Scarpi E; Unit of Biostatistics and Clinical Trials, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST)-IRCCS, 47014 Meldola, FC, Italy. Electronic address: emanuela.scarpi@irst.emr.it.
  • Schirosi L; Functional Biomorphology Laboratory, IRCCS Istituto Tumori "Giovanni Paolo II" di Bari, Italia. Electronic address: l.schirosi@oncologico.bari.it.
  • Scattone A; Pathology Department, IRCCS Istituto Tumori "Giovanni Paolo II" di Bari, Italia. Electronic address: a.scattoneanatopat@alice.it.
  • Mangia A; Functional Biomorphology Laboratory, IRCCS Istituto Tumori "Giovanni Paolo II" di Bari, Italia. Electronic address: a.mangia@oncologico.bari.it.
Transl Oncol ; 12(3): 585-595, 2019 Mar.
Article em En | MEDLINE | ID: mdl-30682679
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2019 Tipo de documento: Article